GABRIELLE ANDERSON: Open Payments
NPI 1346931482 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 12 payments from 9 companies in 2025. Trend: 2023 $36 · 2024 $599 · 2025 $755
Food & beverage: $556Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $245 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Genentech USA, Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| GENZYME CORPORATION | 1 | $36 |
| Kite Pharma, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: RYBREVANT, SARCLISA, KEYTRUDA, JEMPERLI, DARZALEX, Yescarta, Columvi, LUTATHERA.
Industry payments across OR — which companies pay providers there.
